|
Laxman Pai, Opalesque Asia: Chicago-based healthcare private equity firm Sheridan Capital Partners has collected $306 million for its second fund, with total capital commitments significantly above the $250 million target.
The lower-midmarket firm closed Sheridan Capital Partners Fund II with more than double the $150 million that it raised for its debut fund in 2012.
Sheridan is focused on making investments in lower middle-market companies in recession-resistant, non-discretionary markets within the healthcare industry, claimed a press release.
Sheridan Capital Partners Fund II will continue Sheridan's strategy of making control investments in North American founder-owned businesses with $3-15 million of EBITDA.
"We are extremely pleased with the overwhelming support provided by our investor base, which encompasses a high-quality group of internationally diversified insurance companies, fund-of-funds, family offices, and asset managers," stated Jonathan Lewis, Founder & Partner at Sheridan.
Sixpoint Partners served as the exclusive global placement agent for Fund II and Kirkland & Ellis LLP served as fund counsel and legal advisor.
"Sixpoint Partners' continued strategic advice and support throughout the process were instrumental in the successful outcome of the fundraise," said Sean Dempsey, Partner at Sheridan.
"Sheridan's oversubscribed sophomore fundraise in a highly selective environment shows a strong vote of confidence in Jonathan, Sean...................... To view our full article Click here
|
RSS
